NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
18 11 2021
Historique:
received: 29 03 2021
revised: 21 07 2021
accepted: 15 09 2021
pubmed: 13 10 2021
medline: 8 1 2022
entrez: 12 10 2021
Statut: ppublish

Résumé

The heterogeneous family of complexes comprising Polycomb repressive complex 1 (PRC1) is instrumental for establishing facultative heterochromatin that is repressive to transcription. However, two PRC1 species, ncPRC1.3 and ncPRC1.5, are known to comprise novel components, AUTS2, P300, and CK2, that convert this repressive function to that of transcription activation. Here, we report that individuals harboring mutations in the HX repeat domain of AUTS2 exhibit defects in AUTS2 and P300 interaction as well as a developmental disorder reflective of Rubinstein-Taybi syndrome, which is mainly associated with a heterozygous pathogenic variant in CREBBP/EP300. Moreover, the absence of AUTS2 or mutation in its HX repeat domain gives rise to misregulation of a subset of developmental genes and curtails motor neuron differentiation of mouse embryonic stem cells. The transcription factor nuclear respiratory factor 1 (NRF1) has a novel and integral role in this neurodevelopmental process, being required for ncPRC1.3 recruitment to chromatin.

Identifiants

pubmed: 34637754
pii: S1097-2765(21)00754-1
doi: 10.1016/j.molcel.2021.09.020
pmc: PMC8604784
mid: NIHMS1743382
pii:
doi:

Substances chimiques

AUTS2 protein, human 0
Auts2 protein, mouse 0
Chromatin 0
Cytoskeletal Proteins 0
NRF1 protein, human 0
Nrf1 protein, mouse 0
Nuclear Respiratory Factor 1 0
Transcription Factors 0
CREB-Binding Protein EC 2.3.1.48
CREBBP protein, human EC 2.3.1.48
Crebbp protein, mouse EC 2.3.1.48
E1A-Associated p300 Protein EC 2.3.1.48
EP300 protein, human EC 2.3.1.48
Ep300 protein, mouse EC 2.3.1.48

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4663-4676.e8

Subventions

Organisme : NCI NIH HHS
ID : R01 CA199652
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY024376
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS100897
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS050375
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY028102
Pays : United States
Organisme : NIAAA NIH HHS
ID : K99 AA024837
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests D.R. is a cofounder of Constellation and Fulcrum Pharmaceuticals.

Références

Mol Cell. 2019 Jun 6;74(5):1037-1052.e7
pubmed: 31029542
Am J Med Genet B Neuropsychiatr Genet. 2018 Jun;177(4):406-415
pubmed: 29637745
Genomics. 2002 Aug;80(2):129-34
pubmed: 12160723
Nature. 2014 Dec 18;516(7531):349-54
pubmed: 25519132
Genes Dev. 2013 Jun 15;27(12):1318-38
pubmed: 23788621
Neuron. 2009 Mar 26;61(6):852-64
pubmed: 19323995
Am J Med Genet B Neuropsychiatr Genet. 2009 Dec 5;150B(8):1110-7
pubmed: 19259986
Biochim Biophys Acta. 2011 Jul;1813(7):1269-78
pubmed: 20933024
Eur Rev Med Pharmacol Sci. 1998 Mar-Apr;2(2):81-7
pubmed: 10229563
Mol Cell. 2007 Oct 12;28(1):1-13
pubmed: 17936700
Nat Rev Genet. 2021 Jun;22(6):379-392
pubmed: 33500558
Mol Neurodegener. 2018 Oct 17;13(1):56
pubmed: 30333037
Science. 2015 Feb 27;347(6225):1017-21
pubmed: 25722416
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Cell. 2002 Aug 9;110(3):385-97
pubmed: 12176325
Trends Genet. 2013 Oct;29(10):600-8
pubmed: 24008202
Science. 2010 Oct 29;330(6004):612-6
pubmed: 21030644
Am J Hum Genet. 2019 Mar 7;104(3):542-552
pubmed: 30827498
Development. 2008 Apr;135(8):1513-24
pubmed: 18339675
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Genes Dev. 2010 Feb 15;24(4):368-80
pubmed: 20123894
Eur J Hum Genet. 2015 Jun;23(6):803-7
pubmed: 25205402
Mol Cell. 2012 Feb 10;45(3):344-56
pubmed: 22325352
Genes Dev. 2019 Aug 1;33(15-16):903-935
pubmed: 31123062
Development. 2020 Sep 28;147(18):
pubmed: 32988974
Mol Psychiatry. 2010 Jun;15(6):637-46
pubmed: 19546859
Sci Adv. 2020 Jan 10;6(2):eaax4001
pubmed: 31950077
Hum Genet. 2013 Oct;132(10):1141-51
pubmed: 23743675
Brain. 2014 Jun;137(Pt 6):1579-613
pubmed: 24477430
Biochem Biophys Res Commun. 2005 Aug 19;334(1):199-206
pubmed: 15992771
Am J Hum Genet. 2019 Sep 5;105(3):606-615
pubmed: 31474318
Elife. 2017 Oct 09;6:
pubmed: 28990928
Nature. 2011 Jan 20;469(7330):343-9
pubmed: 21248841
Dev Biol. 2013 Sep 15;381(2):482-90
pubmed: 23850772
Transl Psychiatry. 2014 Sep 02;4:e431
pubmed: 25180570
J Med Genet. 2016 Aug;53(8):523-32
pubmed: 27075013
Nat Neurosci. 2013 Sep;16(9):1191-1198
pubmed: 23955559
Elife. 2019 Sep 05;8:
pubmed: 31486770
Am J Med Genet A. 2021 Mar;185(3):877-883
pubmed: 33346930
Cell. 1996 Nov 29;87(5):953-9
pubmed: 8945521
Cell Rep. 2016 Oct 4;17(2):583-595
pubmed: 27705803
Cell. 2006 Apr 21;125(2):315-26
pubmed: 16630819
Am J Hum Genet. 2013 Feb 7;92(2):210-20
pubmed: 23332918
Development. 2013 Jun;140(12):2525-34
pubmed: 23715546
Am J Dis Child. 1963 Jun;105:588-608
pubmed: 13983033
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Cell Rep. 2014 Dec 24;9(6):2166-79
pubmed: 25533347
Science. 2004 Nov 26;306(5701):1574-7
pubmed: 15567868
Sci Adv. 2019 Oct 02;5(10):eaay3068
pubmed: 31616795
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Brain Sci. 2017 May 14;7(5):
pubmed: 28505103
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Genes Dev. 2003 Aug 1;17(15):1823-8
pubmed: 12897052
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Bioinformatics. 2015 Jul 15;31(14):2382-3
pubmed: 25765347
Nat Struct Mol Biol. 2013 Oct;20(10):1147-55
pubmed: 24096405
Cell. 2017 Sep 21;171(1):34-57
pubmed: 28938122
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Science. 2017 Mar 10;355(6329):1081-1084
pubmed: 28280206
Hum Mutat. 2018 May;39(5):666-675
pubmed: 29330883
Cell. 2012 Feb 17;148(4):664-78
pubmed: 22325148
Cell. 2019 Oct 31;179(4):953-963.e11
pubmed: 31675501
Science. 2021 Jan 22;371(6527):
pubmed: 33479123
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Neurosci. 2009 Jul 1;29(26):8438-46
pubmed: 19571134
Nat Biotechnol. 2020 Jun;38(6):708-714
pubmed: 32518404
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
EMBO J. 1999 May 4;18(9):2551-62
pubmed: 10228168
Hum Genet. 2020 Nov;139(11):1363-1379
pubmed: 32424618
Nature. 2010 Mar 11;464(7286):306-10
pubmed: 20075857
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Mol Cell. 2018 Jun 21;70(6):1149-1162.e5
pubmed: 29932905
PLoS Genet. 2010 May 20;6(5):e1000962
pubmed: 20502679
Genes Dev. 1990 Jun;4(6):1023-34
pubmed: 2166701
Cell Stem Cell. 2018 May 3;22(5):726-739.e7
pubmed: 29727681
Gene. 2013 Feb 15;515(1):62-70
pubmed: 23219993
Nat Struct Mol Biol. 2016 Jul;23(7):682-690
pubmed: 27294783
Mol Cell Biol. 2005 Feb;25(4):1354-66
pubmed: 15684387
Mol Cell. 2008 Jan 18;29(1):69-80
pubmed: 18206970
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Cell. 2015 Feb 12;160(4):798-798.e1
pubmed: 25679767
J Biol Chem. 1997 Jul 25;272(30):18732-9
pubmed: 9228045
Nat Cell Biol. 2007 Dec;9(12):1428-35
pubmed: 18037880
Gigascience. 2018 Jun 1;7(6):
pubmed: 29846586
Cell Rep. 2019 Apr 16;27(3):900-915.e5
pubmed: 30995485
Am J Med Genet A. 2003 Jun 1;119A(2):101-10
pubmed: 12749047
Mol Cell Biol. 2001 Jan;21(2):644-54
pubmed: 11134350
Cell Rep. 2014 Nov 6;9(3):1163-70
pubmed: 25437568
J Biosci. 2020;45:
pubmed: 31965994
Nature. 1996 Dec 19-26;384(6610):641-3
pubmed: 8967953

Auteurs

Sanxiong Liu (S)

Department of Biochemistry and Molecular Pharmacology, New York University Langone School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Kimberly A Aldinger (KA)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Chi Vicky Cheng (CV)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Takae Kiyama (T)

Ruiz Department of Ophthalmology and Visual Science, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77030, USA; National Eye Institute, NIH, Bethesda, MD 20892, USA.

Mitali Dave (M)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Hanna K McNamara (HK)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Wukui Zhao (W)

Department of Biochemistry and Molecular Pharmacology, New York University Langone School of Medicine, New York, NY 10016, USA.

James M Stafford (JM)

Department of Biochemistry and Molecular Pharmacology, New York University Langone School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Nicolas Descostes (N)

Department of Biochemistry and Molecular Pharmacology, New York University Langone School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Pedro Lee (P)

Department of Biochemistry and Molecular Pharmacology, New York University Langone School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Stefano G Caraffi (SG)

Struttura Semplice Dipartimentale di Genetica Medica, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Ivan Ivanovski (I)

Struttura Semplice Dipartimentale di Genetica Medica, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; Institute of Medical Genetics, University of Zürich, Zürich, Switzerland.

Edoardo Errichiello (E)

Dipartimento di Medicina Molecolare, Università di Pavia, Pavia, Italy; IRCCS Mondino Foundation, Pavia, Italy.

Christiane Zweier (C)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 10, 91054 Erlangen, Germany; Department of Human Genetics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Orsetta Zuffardi (O)

Dipartimento di Medicina Molecolare, Università di Pavia, Pavia, Italy.

Michael Schneider (M)

Carle Physicians Group, Section of Neurology, St. Christopher's Hospital for Children, Urbana, IL, USA.

Antigone S Papavasiliou (AS)

Neurology, IASO Children's Hospital, Athens, Greece.

M Scott Perry (MS)

Comprehensive Epilepsy Program, Jane and John Justin Neuroscience Center, Cook Children's Medical Center, Fort Worth, TX 76104, USA.

Jennifer Humberson (J)

Division of Genetics, Department of Pediatrics, University of Virginia Children's Hospital, Charlottesville, VA, USA.

Megan T Cho (MT)

GeneDx, Inc., Gaithersburg, MD, USA.

Astrid Weber (A)

Liverpool Women's Hospital, Liverpool, UK.

Andrew Swale (A)

Liverpool Women's Hospital, Liverpool, UK; Manchester Centre for Genomic Medicine, Manchester, UK.

Tudor C Badea (TC)

National Eye Institute, NIH, Bethesda, MD 20892, USA; Research and Development Institute, Transilvania University of Brasov, School of Medicine, Brasov, Romania.

Chai-An Mao (CA)

Ruiz Department of Ophthalmology and Visual Science, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77030, USA; National Eye Institute, NIH, Bethesda, MD 20892, USA.

Livia Garavelli (L)

Struttura Semplice Dipartimentale di Genetica Medica, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

William B Dobyns (WB)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics (Genetic Medicine), University of Washington, Seattle, WA, USA.

Danny Reinberg (D)

Department of Biochemistry and Molecular Pharmacology, New York University Langone School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: danny.reinberg@nyumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH